Travere Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 11/14/2024 | 7.65 M | $107.00 M | 1.97% | 9.83% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 7.56 M | $105.73 M | 100.00% | 9.72% |
| VANGUARD GROUP INC | 11/13/2024 | 6.90 M | $96.56 M | 4.27% | 8.87% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 11/14/2024 | 4.68 M | $65.54 M | 4.51% | 6.02% |
| WOODLINE PARTNERS LP | 11/14/2024 | 4.34 M | $60.72 M | 239.92% | 5.58% |
| MACQUARIE GROUP LTD | 11/14/2024 | 4.27 M | $59.78 M | -2.17% | 5.49% |
| STATE STREET CORP | 11/14/2024 | 2.74 M | $38.29 M | -22.05% | 3.52% |
| EMERALD ADVISERS, LLC | 10/29/2024 | 1.96 M | $27.43 M | 19.76% | 2.52% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 1.88 M | $26.23 M | -14.92% | 2.41% |
| D. E. SHAW & CO., INC. | 11/14/2024 | 1.84 M | $25.74 M | 20.03% | 2.37% |
| NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 1.83 M | $25.63 M | 148.37% | 2.36% |
| FINEPOINT CAPITAL LP | 11/13/2024 | 1.78 M | $24.93 M | 0.31% | 2.29% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 1.73 M | $24.22 M | 3.89% | 2.23% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 1.71 M | $23.99 M | -8.75% | 2.20% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 11/14/2024 | 1.59 M | $22.25 M | -15.85% | 2.04% |
| ASSENAGON ASSET MANAGEMENT S.A. | 10/23/2024 | 1.37 M | $19.23 M | -37.92% | 1.77% |
| KYNAM CAPITAL MANAGEMENT, LP | 11/14/2024 | 1.37 M | $19.19 M | -32.16% | 1.76% |
| MORGAN STANLEY | 11/14/2024 | 1.35 M | $18.88 M | -61.33% | 1.73% |
| BALYASNY ASSET MANAGEMENT L.P. | 11/14/2024 | 1.29 M | $17.98 M | 100.00% | 1.65% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 10/29/2024 | 1.19 M | $16.59 M | 25.97% | 1.52% |
| LOGOS GLOBAL MANAGEMENT LP | 11/14/2024 | 1.10 M | $15.39 M | 100.00% | 1.41% |
| PARKMAN HEALTHCARE PARTNERS LLC | 11/14/2024 | 1.09 M | $15.19 M | 11.98% | 1.40% |
| EVERSEPT PARTNERS, LP | 11/14/2024 | 869,913 | $12.17 M | -20.28% | 1.12% |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 11/13/2024 | 843,300 | $11.80 M | 37.12% | 1.08% |
| CITADEL ADVISORS LLC | 11/14/2024 | 775,089 | $10.84 M | 21.05% | 1.00% |
| PICTET ASSET MANAGEMENT HOLDING SA | 11/12/2024 | 762,908 | $10.69 M | -21.99% | 0.98% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 11/14/2024 | 753,795 | $10.55 M | 100.00% | 0.97% |
| JPMORGAN CHASE & CO | 12/26/2024 | 748,558 | $10.47 M | -4.68% | 0.96% |
| TWO SIGMA ADVISERS, LP | 11/14/2024 | 720,400 | $10.08 M | 30.20% | 0.93% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 702,606 | $9.83 M | -9.77% | 0.90% |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 11/13/2024 | 677,452 | $9.49 M | 6.79% | 0.87% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 567,409 | $7.94 M | -0.21% | 0.73% |
| JANE STREET GROUP, LLC | 11/15/2024 | 553,700 | $7.75 M | 100.00% | 0.71% |
| DEEP TRACK CAPITAL, LP | 11/14/2024 | 531,857 | $7.44 M | -92.78% | 0.68% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 11/08/2024 | 525,381 | $7.35 M | 11.22% | 0.68% |
| GW&K INVESTMENT MANAGEMENT, LLC | 11/07/2024 | 497,925 | $6.97 M | -2.39% | 0.64% |
| WALLEYE CAPITAL LLC | 11/14/2024 | 488,453 | $6.83 M | 83.30% | 0.63% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2024 | 400,000 | $5.60 M | 0.00% | 0.51% |
| INVESCO LTD. | 11/12/2024 | 365,206 | $5.11 M | 1,078.84% | 0.47% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 360,083 | $5.04 M | 14.61% | 0.46% |
| TREXQUANT INVESTMENT LP | 11/12/2024 | 356,708 | $4.99 M | 104.43% | 0.46% |
| READYSTATE ASSET MANAGEMENT LP | 11/14/2024 | 332,939 | $4.66 M | 100.00% | 0.43% |
| UBS GROUP AG | 11/14/2024 | 326,235 | $4.56 M | 148.08% | 0.42% |
| PANAGORA ASSET MANAGEMENT INC | 11/13/2024 | 320,333 | $4.48 M | 252.48% | 0.41% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 11/14/2024 | 313,242 | $4.38 M | 100.00% | 0.40% |
| JANE STREET GROUP, LLC | 11/15/2024 | 311,260 | $4.35 M | -24.06% | 0.40% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2024 | 281,349 | $3.94 M | 741.33% | 0.36% |
| JUMP FINANCIAL, LLC | 11/14/2024 | 276,530 | $3.87 M | 637.81% | 0.36% |
| PDT PARTNERS, LLC | 11/14/2024 | 264,273 | $3.70 M | 10.68% | 0.34% |
| KNOTT DAVID M JR | 11/13/2024 | 258,231 | $3.61 M | -2.91% | 0.33% |
Travere Therapeutics, Inc.institutional Ownership - FAQ's
During the previous two years, 208 institutional investors and hedge funds held shares of Travere Therapeutics, Inc.. The most heavily invested institutionals were:
ARMISTICE CAPITAL, LLC: 7.65 M
BlackRock Funding, Inc. /DE: 7.56 M
VANGUARD GROUP INC: 6.9 M
Rock Springs Capital Management LP: 4.68 M
Woodline Partners LP: 4.34 M
MACQUARIE GROUP LTD: 4.27 M
106.29% of Travere Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 90.34 M shares in the last 24 months. This purchase volume represents approximately $1.54 B in transactions.